United Therapeutics UTHR
Ownership & positioning
Who holds it, who is betting against it, and where the big money is moving
Short-sale volume as % of daily volume
Large-order net flow, last 20 sessions
Net of large-order buying minus selling, in USD. Over this window: +$3.66M (13 inflow days, 7 outflow days).
Net flow by order size, last 20 sessions
Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.
The five largest holders on file together own 33.8% of shares outstanding.
Largest holders
By investor type
Reported short interest has fallen from 4.93% to 4.28% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).
Recent institutional activity
| Holder | Type | Period | Share change | New stake |
|---|---|---|---|---|
| Amundi Asset Management | Mutual Fund | 2026/Q4 | +769,804 | 2.3% |
| Citadel Advisors LLC | Hedge Fund | 2026/Q4 | +623,772 | 2.2% |
| Wellington Management Group | Mutual Fund | 2026/Q4 | +520,580 | 4.5% |
| Invesco Capital Management LLC | Mutual Fund | 2026/Q4 | +358,112 | 1.8% |
| BlackRock | Mutual Fund | 2026/Q4 | +280,633 | 13.1% |
| Victory Capital Management Inc. | Mutual Fund | 2026/Q4 | +226,239 | 0.6% |
| Deep Track Capital, LP | VC/PE Fund | 2026/Q4 | +176,424 | 0.7% |
| Balyasny Asset Management L.P. | Hedge Fund | 2026/Q4 | +114,730 | 0.3% |
| Longaeva Partners L.P. | Mutual Fund | 2026/Q4 | +106,803 | 0.3% |
| First Trust Advisors L.P. | Mutual Fund | 2026/Q4 | +100,610 | 0.8% |
| Swedbank Robur Fonder AB | Mutual Fund | 2026/Q4 | +85,030 | 1.0% |
| Deerfield Management Company, L.P. | Hedge Fund | 2026/Q4 | +83,598 | 1.3% |
| Eagle Health Investments LP | Hedge Fund | 2026/Q4 | +79,678 | 0.2% |
| Caption Management, LLC | Hedge Fund | 2026/Q4 | +76,401 | 0.2% |
| Arrowstreet Capital, Limited Partnership | Mutual Fund | 2026/Q4 | +73,619 | 0.4% |
Institutional buy/sell activity by reporting period, largest moves first.
Insider transactions
| Date | Insider | Title | Transaction | Shares | Price | Held after |
|---|---|---|---|---|---|---|
| 11 Nov 2026 | Martine Rothblatt | Chairperson & CEO | Derivative Exercise and Sale | -9,500 | $597.33 | 668,728 |
| 8 Nov 2026 | Christopher Patusky | Independent Vice Chairman & Lead Independent Director | Derivative Exercise and Sale | -1,210 | $580.00 | 3,240 |
| 5 Nov 2026 | Martine Rothblatt | Chairperson & CEO | Derivative Exercise and Sale | -9,500 | $568.68 | 668,728 |
| 4 Nov 2026 | Paul Mahon | General Counsel | Derivative Exercise and Sale | -8,300 | $602.72 | 45,172 |
| 2 Nov 2026 | Martine Rothblatt | Chairperson & CEO | Derivative Exercise and Sale | -9,500 | $605.97 | 668,728 |
| 1 Nov 2026 | Martine Rothblatt | Chairperson & CEO | Derivative Exercise and Sale | -9,500 | $598.84 | 668,728 |
| 29 Oct 2026 | Martine Rothblatt | Chairperson & CEO | Derivative Exercise and Sale | -9,500 | $608.05 | 668,728 |
| 28 Oct 2026 | Martine Rothblatt | Chairperson & CEO | Derivative Exercise and Sale | -9,500 | $599.30 | 668,728 |
| 27 Oct 2026 | Martine Rothblatt | Chairperson & CEO | Derivative Exercise and Sale | -9,500 | $588.39 | 668,728 |
| 26 Oct 2026 | Martine Rothblatt | Chairperson & CEO | Derivative Exercise and Sale | -9,500 | $592.84 | 668,728 |
| 25 Oct 2026 | Martine Rothblatt | Chairperson & CEO | Derivative Exercise and Sale | -9,500 | $592.92 | 668,728 |
| 22 Oct 2026 | Martine Rothblatt | Chairperson & CEO | Derivative Exercise and Sale | -9,500 | $588.00 | 668,728 |
| 21 Oct 2026 | Martine Rothblatt | Chairperson & CEO | Derivative Exercise and Sale | -9,500 | $590.40 | 668,728 |
| 20 Oct 2026 | Martine Rothblatt | Chairperson & CEO | Derivative Exercise and Sale | -9,500 | $566.43 | 668,728 |
| 19 Oct 2026 | Martine Rothblatt | Chairperson & CEO | Derivative Exercise and Sale | -9,500 | $563.56 | 668,728 |
| 18 Oct 2026 | Martine Rothblatt | Chairperson & CEO | Derivative Exercise and Sale | -9,500 | $556.88 | 668,728 |
| 15 Oct 2026 | Martine Rothblatt | Chairperson & CEO | Derivative Exercise and Sale | -9,500 | $543.85 | 668,728 |
| 14 Oct 2026 | Martine Rothblatt | Chairperson & CEO | Derivative Exercise and Sale | -9,500 | $551.50 | 668,728 |
| 14 Oct 2026 | Paul Mahon | General Counsel | Intent to Sell (Form 144) | -8,300 | $544.30 | – |
| 14 Oct 2026 | Paul Mahon | General Counsel | Derivative Exercise and Sale | -8,300 | $546.56 | 45,172 |
From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.
Short interest, by report
| Report date | Shares short | % of float | Days to cover |
|---|---|---|---|
| 30 Oct 2026 | 1,837,654 | 4.3% | 3.5 |
| 15 Oct 2026 | 2,457,723 | 5.7% | 2.6 |
| 30 Sep 2026 | 3,596,948 | 8.4% | 3.6 |
| 15 Sep 2026 | 2,800,470 | 6.5% | 3.9 |
| 31 Aug 2026 | 2,059,685 | 4.8% | 4.8 |
| 14 Aug 2026 | 2,112,367 | 4.9% | 3.5 |
No comments yet — be the first to weigh in on UTHR.
Sign in to join the discussion.